0002046638-24-000001.txt : 20241202 0002046638-24-000001.hdr.sgml : 20241202 20241202142212 ACCESSION NUMBER: 0002046638-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241202 DATE AS OF CHANGE: 20241202 EFFECTIVENESS DATE: 20241202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exxel Pharma, INC. CENTRAL INDEX KEY: 0002046638 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-530836 FILM NUMBER: 241518416 BUSINESS ADDRESS: STREET 1: C/O CASSELS SUITE 2200, RBC PLACE CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 720-261-1109 MAIL ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. STE 100 CITY: AURORA STATE: CO ZIP: 80045 D 1 primary_doc.xml X0708 D LIVE 0002046638 Exxel Pharma, INC. 12635 East Montview Blvd Suite 134 Aurora CO COLORADO 80045 720-261-1109 BRITISH COLUMBIA, CANADA None None Corporation true Soren Mogelsvang 12635 East Montview Blvd Suite 134 Aurora CO COLORADO 80045 Executive Officer Director Guy Yachin 12635 East Montview Blvd Suite 134 Aurora CO COLORADO 80045 Director Biotechnology $1 - $1,000,000 06b false 2024-11-20 false true false 125000 Joseph Gunnar & Co, LLC 24795 None None 1000 RXR Plaza Uniondale NY NEW YORK 11556 TX TEXAS false 600000 600000 0 $675,000 Principal Amount of Debentures issued for $600,000 false 1 60000 0 0 false Exxel Pharma, INC. /s/ Soren Mogelsvang Soren Mogelsvang CEO 2024-12-02